Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Amortization of Deferred Charges (2016 - 2026)

Omnicell's (OMCL) quarterly Amortization of Deferred Charges came in at $304000.0 in Q2 2026, up 3.4% year-over-year from $294000.0 in Q2 2025, and down 38.83% quarter-over-quarter from $497000.0 in Q1 2026.

Analysis

Omnicell (OMCL) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Amortization of Deferred Charges for 11 consecutive years, with $304000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 3.4% year-over-year to $304000.0 in Q2 2026; TTM through Jun 2026 was $1.6 million, a 40.41% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 30.02% from the prior year.
  • Amortization of Deferred Charges was $304000.0 for Q2 2026 at Omnicell, down from $497000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $1.3 million in Q4 2023 and troughed at $294000.0 in Q2 2025.
  • A 5-year average of $749388.9 and a median of $772500.0 in 2023 frame the typical range for Amortization of Deferred Charges.
  • Across the five-year window, Amortization of Deferred Charges surged 31.39% in 2022 and sank 62.21% in 2025, its largest moves.
  • Over 5 years, Amortization of Deferred Charges stood at $1.0 million in 2022, then rose by 20.61% to $1.3 million in 2023, then plunged by 30.76% to $871000.0 in 2024, then plunged by 43.05% to $496000.0 in 2025, then plunged by 38.71% to $304000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $304000.0 (Q2 2026), $497000.0 (Q1 2026), and $496000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 304,000.00
Mar 31, 2026 497,000.00
Dec 31, 2025 496,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 294,000.00
Mar 31, 2025 735,000.00
Dec 31, 2024 871,000.00
Sep 30, 2024 780,000.00
Jun 30, 2024 778,000.00
Mar 31, 2024 971,000.00
Dec 31, 2023 1.26 Mn
Sep 30, 2023 773,000.00
Jun 30, 2023 772,000.00
Mar 31, 2023 1.05 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 768,000.00
Jun 30, 2022 766,000.00
Mar 31, 2022 1.04 Mn
Dec 31, 2021 870,000.00
Sep 30, 2021 589,000.00